Key-Obs will be present at Eunethydis ADHD Conference, Amsterdam, 26-28 May 2010 - Key-Obs' news -
About Key-Obs, partner for in vivo research,
Key-Obs is a preclinical Contract Research Organisation (CRO) specialized in central nervous system.
Key-Obs offers in vivo models to evaluate drug efficacy and behavioural tests dedicated to the phenotyping of transgenic mice.
Mission,
To provide our research expertise to your R&D projects, in order to progress efficiently toward the clinical studies...Key-Obs Website -
Blog Archive
-
▼
2010
(51)
-
▼
April
(13)
- GenoSplice technology : A new publication is avail...
- INNOPSYS : Mapix Version 5.0.0
- Imaxio : installation of the new Illumina Ultra Hi...
- Indicia Biotechnology : Gliadys project with IDD B...
- The VECtoBrain project coordinated by VECT-HORUS
- Key-Obs will be present at Eunethydis ADHD Confer...
- Physiogenex to present at the KinMet 2010 & ATVB 2...
- IPSOGEN : Option to Acquire License on TET2 abnorm...
- NOKAD has closed a second round of financing for 1...
- CREAPHARM OPENS U.S. LOCATION FOR EXPANSION OF CYT...
- Nosobio : support of Oséo-France for its antibioti...
- Neorphys : new facility with extended space
- Nanobiotix : ‘proof of concept’ for its nanopartic...
-
▼
April
(13)